Trade Summary

4 days ago, AUERBACH ALAN H, serving as President and CEO at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 44,058 shares at $8.26 per share, for a total transaction value of $364,051.25. Following this transaction, AUERBACH ALAN H now holds 7,261,671 shares of PBYI.

This sale represents a 0.60% decrease in AUERBACH ALAN H's stake in the company.

The trade was executed on Monday, July 6, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, July 9, 2026 (accepted Jul 8, 8:21 PM ET), 3 days after the trade was made.

PUMA BIOTECHNOLOGY, INC. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.